CG MedTechLtd マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Ju mi Chung

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	0.006%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

更新なし

Recent updates

Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

May 04

We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

Jan 11

CEO（最高経営責任者

Ju mi Chung

less than a year

在職期間

Ju mi Chung is Chief Executive Officer of Innosys Co. Ltd. from May 2024.

CG MedTechLtd マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

Recent updates

Innosys Co., Ltd. (KOSDAQ:A056090) agreed to acquire GDS Co., Ltd. for KRW 4 billion.

Innosys Co., Ltd. announced that it has received KRW 10.00000001 billion in funding from CG Bio Co., Ltd.

Edisoninno Co., Ltd. announced that it has received KRW 9.999995684 billion in funding from J-Space Holdings Co., Ltd.

Edisoninno Co., Ltd. announced that it has received KRW 20 billion in funding

Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

New 90-day low: ₩4,400

We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

New 90-day high: ₩5,350

New 90-day low - ₩4,220

CEO（最高経営責任者

在職期間

CG MedTechLtd マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Recent updates

Innosys Co., Ltd. (KOSDAQ:A056090) agreed to acquire GDS Co., Ltd. for KRW 4 billion.

Innosys Co., Ltd. announced that it has received KRW 10.00000001 billion in funding from CG Bio Co., Ltd.

Edisoninno Co., Ltd. announced that it has received KRW 9.999995684 billion in funding from J-Space Holdings Co., Ltd.

Edisoninno Co., Ltd. announced that it has received KRW 20 billion in funding

Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

New 90-day low: ₩4,400

We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

New 90-day high: ₩5,350

New 90-day low - ₩4,220

CEO（最高経営責任者

在職期間

マネジメント基準チェック /04